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Abstract
Hereditary hearing loss is a clinically and genetically heterogeneous disorder. More than 80
genes have been implicated to date, and with the advent of targeted genomic enrichment
and massively parallel sequencing (TGE+MPS) the rate of novel deafness-gene identifica-
tion has accelerated. Here we report a family segregating post-lingual progressive autoso-
mal dominant non-syndromic hearing loss (ADNSHL). After first excluding plausible
variants in known deafness-causing genes using TGE+MPS, we completed whole exome
sequencing in three hearing-impaired family members. Only a single variant, p.Arg185Pro
in HOMER2, segregated with the hearing-loss phenotype in the extended family. This
amino acid change alters a highly conserved residue in the coiled-coil domain of HOMER2
that is essential for protein multimerization and the HOMER2-CDC42 interaction. As a scaf-
folding protein, HOMER2 is involved in intracellular calcium homeostasis and cytoskeletal
organization. Consistent with this function, we found robust expression in stereocilia of hair
cells in the murine inner ear and observed that over-expression of mutant p.Pro185
HOMER2mRNA causes anatomical changes of the inner ear and neuromasts in zebrafish
embryos. Furthermore, mouse mutants homozygous for the targeted deletion of Homer2
present with early-onset rapidly progressive hearing loss. These data provide compelling
evidence that HOMER2 is required for normal hearing and that its sequence alteration in hu-
mans leads to ADNSHL through a dominant-negative mode of action.
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Author Summary
The most frequent sensory disorder worldwide is hearing impairment. It impacts over 5%
of the world population (360 million persons), and is characterized by extreme genetic het-
erogeneity. Over 80 genes have been implicated in isolated (also referred to as ‘non-
syndromic’) hearing loss, and abundant evidence supports the existence of many more
‘deafness-causing’ genes. In this study, we used a sequential screening strategy to first ex-
clude causal mutations in known deafness-causing genes in a family segregating autosomal
dominant non-syndromic hearing loss. We next turned to whole exome sequencing and
identified a single variant—p.Arg185Pro in HOMER2—that segregated with the pheno-
type in the extended family. To validate the pathological significance of this mutation, we
studied two animal models. In zebrafish, we overexpressed mutant HOMER2 and ob-
served inner ear defects; and in mice we documented robust expression in stereocilia of co-
chlear hair cells and demonstrated that its absence causes early-onset progressive deafness.
Our data offer novel insights into gene pathways essential for normal auditory function
and the maintenance of cochlear hair cells.
Introduction
Targeted genomic enrichment and massively parallel sequencing (TGE+MPS) have revolution-
ized the field of hereditary hearing loss (HHL) by making comprehensive genetic testing for
deafness a clinical reality and by accelerating the discovery of novel deafness-causing genes
[1,2]. To date over 80 genes have been causally implicated in non-syndromic hearing loss
(NSHL; Hereditary Hearing Loss Homepage). The proteins encoded by these genes are in-
volved in a broad array of molecular and cellular mechanisms essential for the development
and maintenance of normal auditory function [3]. At the centerpiece of this intricate system
are the outer and inner hair cells (OHCs, IHCs)—key structures in the mechanotransduction
process by which mechanical stimuli are translated into electrical impulses [4]. The precise and
efficient tuning of OHCs and IHCs is closely linked to their anatomical integrity and the coor-
dinated movement of their apical stereocilia.
The Homer proteins are scaffolding proteins crucial to many intracellular signaling cascades;
their function underpins a variety of neuronal processes ranging from calcium homeostasis and
cytoskeletal organization to synaptic plasticity associated with learning and memory [5,6].
Homer proteins are encoded by three genes;HOMER1, 2, and 3 (MIM 604798, MIM 604799
and MIM 604800, respectively) that are translated into multiple isoforms as a result of alterna-
tive splicing [7]. All isoforms share an N-terminal conserved EVH1 (Ena VASP Homology 1)
domain, which binds proline-rich regions of target proteins. The long isoforms (HOMER1b
and c, HOMER2, HOMER3) additionally have a coiled-coil (CC) region and leucine zipper mo-
tifs in their divergent C-termini [8]. The CC region is required for homo/hetero-multimeriza-
tion to form tetrameric hubs (in which the CC domains align in a parallel fashion) and for
interaction with Rho family GTPase proteins like CDC42 (MIM 116952) [9–11]. Although the
short isoforms lack CC domains and therefore do not formmultimers, like their longer counter-
parts they bind target proteins through their EVH1 domain. This interaction regulates the activ-
ity of proteins involved in Ca2+ signaling complexes including metabotropic glutamate
receptors (mGluR) [12], inositol tri-phosphate receptors (IP3R) [8] and transient receptor po-
tential canonical channels (TRPC) [13]. Homer proteins also regulate basal cytosolic calcium
via an interaction with the plasma membrane calcium reuptake pump, PMCA [14,15].
HOMER2 Disruption Causes Non-syndromic Hearing Loss
PLOS Genetics | DOI:10.1371/journal.pgen.1005137 March 27, 2015 2 / 17
to RAC. The funders had no role in study design,
data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
Aberrant Homer signaling has been associated with several developmentally related neuro-
logical syndromes including Fragile X syndrome, epilepsy, addiction, schizophrenia, neuro-
pathic pain and Alzheimer’s disease [16–19]. To this list we now add autosomal dominant
NSHL (ADNSHL).
Results and Discussion
Clinical description and progression of hearing loss
The family segregating the deafness-causing mutation inHOMER2 (MIM 604799; RefSeq
NM_004839) is a multi-generational kindred of European descent (Fig 1A). Pure tone audio-
metric evaluation of affected members showed bilateral post-lingual progressive hearing loss
that segregated as an autosomal dominant trait; bone conduction thresholds excluded conduc-
tive hearing impairment. Clinical examination was negative for any findings consistent with
syndromic hearing loss and also ruled out autoimmune phenotypes. Hearing impairment had
a typical onset in the first decade of life in the high frequencies, with significant subsequent
progression of hearing loss over all frequencies. To evaluate progression at each frequency, we
performed linear regression analyses of threshold on age [20]. The resulting annual threshold
deterioration (ATD) was 1.2 to 1.6 dB per year (Fig 1B, S1 Fig). The age-related typical audio-
gram (ARTA) derived from these data confirmed the down-sloping audiometric configuration
and demonstrated fairly similar progression across all frequencies.
Whole exome sequencing identifies a mutation in HOMER2
Our initial strategy was to screen one family member (III.10) for pathogenic variants in known
deafness-causing genes using a deafness-specific TGE+MPS panel (OtoSCOPE) [21]. Plausible
pathogenic variants were excluded (S1 Table). Whole exome sequencing (WES) was therefore
completed on three affected family members (II.2, IV.5, and IV.10) and variants were filtered
according to guidelines detailed in Materials and Methods section [22].
The resultant final candidate variant lists included 163, 150 and 158 nucleotide changes for
these three individuals, respectively (S1 Table). Of these variants, only four were shared
amongst the three sequenced exomes (S2 Table) and only one segregated with the ADNSHL
phenotype in the extended family (Fig 1A and 1C). The segregating variant, c.554G>C; p.
Arg185Pro inHOMER2 on chromosome 15q25.2, is a novel non-synonymous change that
substitutes a highly conserved arginine for a proline, a substitution that is predicted to be path-
ogenic and disease-causing by Polyphen2, LRT, SIFT and MutationTaster (S3 Table).
HOMER2 belongs to the homer family of post-synaptic density scaffolding proteins and is
expressed as two isoforms, HOMER2 isoform 1 (NM_004839, 343 aa) and isoform 2
(NM_199330.2, 354 aa), which differ by 11 amino acids. The p.Arg185Pro variant lies in the CC
domain (Fig 1D). A lysine is found at the orthologous position in HOMER1 and HOMER3,
which like arginine is a basic polar amino acid that confers similar chemico-physical properties
to the protein. Proline, in contrast, is non-polar and is predicted to alter the conformational
structure of the CC domain or affect its ability to multimerize and/or interact with partner
proteins.
Homer2 localizes to stereocilia of hair cells in the murine cochlea
Homer2 is extensively expressed in the CNS throughout development [23]. It is also expressed
in skeletal muscle, heart, liver, spleen, lung and kidney. To investigate and define its expression
pattern in inner ear, we immuno-labeled whole mount P2 mouse cochlea with HOMER2 anti-
body. Organ of Corti expression was particularly enriched in the tips of stereocilia of both
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Fig 1. Pedigree, clinical data, HOMER2mutation and protein structure. (A) The pedigree of a five-generation family segregating progressive ADNSHL.
DNA samples were obtained for 9 unaffected and 10 affected individuals. The partially filled symbol represents a two-year-old female who carries the
HOMER2mutation but in whom a formal ABR has not been performed. Individuals who underwent TGE+MPS using either the deafness panel (OtoSCOPE)
or WES are marked with an O or W, respectively. Genotypes of participating family members are shown below each symbol in single letter amino acid
nomenclature: P for Proline and R for Arginine. (B) Age-related typical audiograms (ARTA). Binaural mean air conduction thresholds (dB HL) are presented
for the ages 10–70 years. Hearing levels ranged from 0 to 120 dB depending on age and frequency; the annual threshold deterioration (ATD) was 1.2–1.6
dB/year at all frequencies. (C) Representative chromatograms from wild-type and mutant sequences. (D)Diagram of HOMER2 structure; the amino acid
numbering indicates the beginning and end of the EVH1 and CC domains. The CC includes the CDC42 binding domain (CBD), Leucine Zipper-A (LZA) and
Leucine Zipper-B (LZB). The position of the p.Arg185Pro mutation is shown in red.
doi:10.1371/journal.pgen.1005137.g001
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IHCs and OHCs (Fig 2), consistent with data by Hertzano and colleagues using cell sorting and
RNASeq to identify Homer2 enrichment in the sensory cells of P0–P1 mice [24]. This expres-
sion pattern suggests a role for HOMER2 in hair bundle function, formation, development
or maintenance.
The p.Arg185Pro mutation does not affect subcellular localization in
mammalian cells
To evaluate whether the p.Arg185Pro mutation affects subcellular localization, we transfected
HEK293T and COS7 cells with cMYC-tagged HOMER2WT proteins or FLAG-tagged
HOMER2p.Arg185Pro. Both wild-type (WT) and mutant proteins distributed in a diffuse manner
in the cytoplasm with no obvious differences in localization patterns (S2 Fig). A similar pattern
of distribution was observed when bothWT and mutant constructs were cotransfected. These
data indicate that the p.Arg185Pro mutation does not alter subcellular localization of HOMER2.
Overexpression of mutant HOMER2 in zebrafish embryos causes inner
ear and neuromast defects
To assess the impact of the p.Arg185Pro mutation in HOMER2 in vivo we used the zebrafish
model. Zebrafish hair cells share similarities with their mammalian counterparts in morpholo-
gy and function. They reside inside the otic vesicles and in the neuromasts of the lateral line
system, a sensory system on the surface of fish important for sensing propulsion through
water, capturing prey, or avoiding predators and obstacles. The zebrafish homer2
(NP_001018470.1) is 67% identical to human HOMER2 and is expressed mostly in the devel-
oping musculature although there is faint expression in the otic capsule at 24 hours post-fertili-
zation (hpf) [25]. We used morpholino antisense oligonucleotides (S4 Table) to induce altered
splicing and protein truncation. Although knockdown of homer2 altered neither ear size nor
morphology (p>0.5) (S3 Fig), injection of in vitro synthesized mRNA encoding HOMER2
P185-mutant RNA (P185RNA) resulted in significantly smaller ear size in larvae as compared
to injections with WT HOMER2 (wtRNA) (p<0.001) (Fig 3A i-iii and 3B; S4 Fig). In addition,
the number of kinocilia detected per neuromast was decreased (p = 0.03) (Fig 3C i-iii and 3D).
We also noted that P185RNA-injected embryos exhibited shorter kinocilia, an observation that
needs to be confirmed with more detailed methods. These results show that HOMER2 plays an
Fig 2. Homer2 expression in P2mouse inner ear. (A) Staining with F-actin shows three rows of OHCs and one row of IHCs in the cochlea. (B) Homer2
staining in the OHCs and IHCs shows localization to stereocilia. (C) Merged pictures showing co-localization of Homer2 with F-actin in HC stereocilia. (D)
Zoomed view of OHCs shows pronounced localization of Homer2 to the tips of stereocilia. Scale bar represents 10μm.
doi:10.1371/journal.pgen.1005137.g002
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essential role in the normal development and/or maintenance of hair cells in the zebrafish
inner ear and that the p.Arg185Pro mutation has a dominant-negative effect on this process.
Dominant-negative activity has been previously validated in vivo for another homer protein,
HOMER1. Its long isoforms, HOMER1b and 1c, are constitutively expressed while the short
isoform, HOMER1a is an immediate early gene product that is rapidly and transiently induced
by high synaptic activity [26]. Because HOMER1a lacks the CC domain, it cannot form multi-
mers but it can still competitively bind the target proteins of HOMER1b and 1c, suggesting
that relative expression of each of these homer proteins is critical [27–29]. The importance of
this dynamic balance has been validated by the observation that overexpression of Homer1a in
a mouse impedes normal development and through a dominant-negative effect leads to signifi-
cant defects in motor coordination and learning, with increased levels of fear-associated behav-
ior and anxiety [30].
Homer2-/-mice exhibit early onset progressive hearing loss
The role of Homer2 has been thoroughly studied in the murine brain and pancreas where it
functions to decrease the intensity of Ca2+ signaling by reducing signaling by G protein-coupled
receptors (GPCRs) [31]. Mice homozygous for the targeted deletion of homer2 (Homer2-/-mice
generated by deletion of exon 3 [32]) show extensive behavioral and neurochemical similarities
to cocaine or alcohol-sensitized animals, and demonstrate Homer2 involvement in appetitive
pathways underlying responses to those drugs and their induced behavioral/cellular neuroplas-
ticity within the nucleus accumbens [33,34]. Studies inHomer2-/- Homer3-/-mice show upregu-
lation of cytokine expression and an increase in effector-memory T cells leading to an
Fig 3. Over-expression of wtRNA and P185RNA in zebrafish embryos. (A)Otic capsule morphology in non-injected (i, n = 26), wtRNA-injected (ii, n = 26)
and P185RNA-injected (iii, n = 27) embryos at 72 hpf. Scale bar represents 50μm. Embryos are mounted anterior to the left. (B) Comparison of otic capsule
morphology betweenWT and mutant RNA injected zebrafish shows reduced inner ear size in mutant RNA injected larvae (p<0.001). (C) Hair cell kinocilia in
P185RNA-injected larvae (iii) show fewer kinocilia as compared to non-injected (i) and wtRNA-injected larvae (ii). Scale bar represents 5μm. (D) Kinocilia
count per neuromast comparison between wtRNA-injected (n = 56) and P185RNA-injected (n = 55). All data are presented as the mean ± SEM and are
derived from at least triplicates (*P< 0.05 as compared with controls considered significant).
doi:10.1371/journal.pgen.1005137.g003
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autoimmune-like pathology, indicating that Homer2 negatively regulates T cell activation [35].
To evaluate cochlear function ofHomer2-/-mice, we measured auditory brainstem responses
(ABR), an electrophysiological hearing test that reflects the activity of afferent auditory neurons
downstream of IHCs. We examined hearing in 2-, 4- and 8-week-oldHomer2-/-,Homer2+/- and
WTHomer2+/+mice and observed no differences between age-matchedWT andHomer2+/- ani-
mals (P>0.2), howeverHomer2-/-mice showed progressive hearing loss (Fig 4). At P14
Fig 4. Homer2-/-mice have early onset progressive hearing loss. (A-D) Auditory brainstem responses (ABR) to broad band clicks (A) and tone bursts
(B-D) at 8, 16, and 32 kHz in P14, P28 and P56Homer2-/-, Homer2+/- andWTmice. (A) Raised mean ABR thresholds (dB SPL) were detected as early as
P14 in Homer2-/-mice and continued to increase with age. (B) At P14Homer2-/-mice had severe-to-profound hearing loss at high frequencies (16 kHz and
32 kHz) whereas hearing thresholds in their WT andHomer2+/- littermates were in the normal range. (C) At P28Homer2-/-mice had hearing loss in the lower
frequencies. (D) P56Homer2-/-mice had profound hearing loss across all tested frequencies (click, 8 kHz, 16 kHz and 32 kHz). (E-G) DPOAE levels. (E) In
P14Homer2-/-mice, DPOAE amplitudes are significantly lower in the high frequencies (16, 22.6, and 32.0 kHz) as compared to their WT andHomer2+/-
littermates. (F) In P28Homer2-/-mice, DPOAE amplitudes are lower in nearly all frequencies (5.7, 8, 11.3, 16, 22.6, and 32.0 kHz). (G) In P56Homer2-/-
mice, DPOAEs deteriorate across all frequencies consistent with profound hearing loss. (H) Representative Alexa-Fluor-488-phalloidin immunofluorescence
shows no obvious hair cell death in cochleae in P56Homer2-/- (n = 5), Homer2+/- (n = 4) andWT (n = 3) mice. Mean ABR thresholds and DPOAE amplitudes:
Homer2 -/-mice are shown in red; Homer2+/- in blue; andWTmice in green. The number of ears tested is shown in parentheses. P-values were calculated
with One-way ANOVA and post-hoc T-test analysis. Asterisks indicate statistical significance: *P<0.05, **P<0.005, ***P<0.0005. Error bars represent
SEM. Scale bar represents 10μm.
doi:10.1371/journal.pgen.1005137.g004
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Homer2-/-mice had slightly elevated broad band click ABR thresholds as compared to
Homer2+/-mice [Homer2-/- (n = 11); 67.3±2.56 verseHomer2+/- (n = 17); 61.20±2.50 db SPL].
This difference progressively increased ([P28Homer2-/- (n = 10); 82.0±5.40 db SPL vs
Homer2+/- (n = 6); 59.20±2.71 db SPL]; [P56Homer2-/- (n = 5); 100.0±0.0 db SPL vsHomer2+/-
(n = 9); 55.6±1.76 db SPL]) (Fig 4A). Tone bursts showed that P14Homer2-/- mice had pro-
found deafness at 32 kHz and that the rate of hearing deterioration at 8 kHz was dramatic (P14,
55.5±2.28 dbSPL; P28, 73.0±6.84; P56, 87.0±1.22 dbSPL) (Fig 4B-4D). We assessed OHC func-
tion using distortion product otoacoustic emissions (DPOAEs) and observed no significant dif-
ferences in DPOAE thresholds betweenHomer2+/- andWTmice (P>0.05). InHomer2-/-mice,
significant decreases in mid- to high-frequency DPOAE levels were seen at P14 and P28 that
culminated in profound deafness at all frequencies by P56 (Fig 4E-4G).
To determine whether the auditory deficit inHomer2-/-mice was secondary to hair cell loss
we analyzed whole mount preparations of the organ of Corti at P56. No differences in IHCs
and OHCs were observed in any animals regardless of genotype indicating the absence of
Homer2 does not impair hair cell formation and development, and that the hearing loss in
Homer2-/- mice is not due to hair cell death (Fig 4H). Whether the hearing deficit in these mice
is due to abnormal hair bundle morphology remains to be elucidated. We additionally investi-
gated spiral ganglion morphology and found no obvious indication of spiral ganglion degener-
ation inHomer2-/-mice as compared to their WT littermates (S5 Fig).
p.Arg185Pro mutation exerts its effect through a dominant-negative
mechanism
In aggregate, our data show that HOMER2 is required for normal hearing. Its complete ab-
sence in mice leads to early onset progressive hearing loss starting at the high frequencies and
rapidly involving all frequencies. The recessive phenotype exhibited by null alleles of Homer2
makes it a strong candidate for autosomal recessive hearing loss due to loss of function in hu-
mans as well. The absence of a disease phenotype inHomer2+/- mice suggests that haploinsuffi-
ciency does not cause hearing loss. Together with results obtained from zebrafish experiments,
these data strongly suggest that the p.Arg185Pro mutation in HOMER2 exerts its effect
through a dominant-negative mechanism on wild-type protein by either inhibiting multimeri-
zation or competing for other partner proteins.
In defining the effect of the p.Arg185Pro mutation in HOMER2 at a molecular level, we be-
lieve two hypotheses warrant consideration. One hypothesis posits that HOMER2 exerts its
function by regulating actin dynamics in stereocilia through its interaction with CDC42, a
highly conserved small GTPase of the RHO family that fine-tunes actin-turnover (S6 Fig).
HOMER2 is known to couple with and regulate CDC42 through its CDC42-binding domain
(CBD) within the CC domain (Fig 1D) [10]. In HeLa cells, CDC42 induces the formation of
filopodia-like protrusions, while overexpression of HOMER2 suppresses this phenotype [36].
In the cochlea, CDC42 localizes to stereocilia membranes and its targeted deletion in murine
HCs leads to their degeneration and results in progressive hearing loss particularly at the high
frequencies, a phenotype similar to the humanHOMER2mutant phenotype and theHomer2-/-
murine phenotype [36].
A second hypothesis focuses on the role of HOMER2 in cytoplasmic Ca2+ control. Several
studies have shown that HOMER2 regulates a number of Ca2+ handling proteins including
TRPC and PMCA channels. Two TRPCs—TRPC3 (MIM 602345) and TRPC6 (MIM 603652)—
are expressed in both sensory neurons and cochlear hair cells and are required for normal func-
tion. Their targeted deletion in mice causes significant dysregulation of Ca2+ re-entry that leads
to hearing impairment and vestibular deficits [37]. While both proteins are potentially
HOMER2 Disruption Causes Non-syndromic Hearing Loss
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interacting partners for HOMER2, to date only an interaction with TRPC1 (MIM 602343) has
been established [13]. However, a recent study has demonstrated a critical role for Homer2 in
modulating PMCA activity by regulating the duration of the Ca2+ signaling in parotid acinar
cells [38]. This finding suggests a possible role for Homer2 in cytosolic Ca2+ clearance to balance
TRPC-mediated Ca2+ influx and PMCA-mediated Ca2+ extrusion. A suitable interacting partner
of HOMER2may be the PMCA2 pump (MIM 108733), which represents the only system for
clearance of Ca2+ from hair cell stereocilia [39]. While both of these hypotheses are attractive,
further functional studies are needed to identify the partner proteins of HOMER2 in inner ear
and investigate the effect of the p.Arg185Pro mutation on these interactions.
In summary, we have identifiedHOMER2 as essential to normal auditory function and
have shown that the p.Arg185Pro HOMER2 mutation causes ADNSHL through a dominant-
negative mechanism of action, thus expanding the phenotypic spectrum associated with
Homer protein dysfunction.
Materials and Methods
Subjects and ethics statement
A five-generation family of European descent segregating bilateral post-lingual progressive
ADNSHL was ascertained for this study (Fig 1A). After obtaining written informed consent
from all participants with approval by the Institutional Review Board of the University of Iowa,
clinical examination of the subjects was completed to exclude any additional and/or syndromic
findings. Blood samples were obtained from 19 family members.
Audiograms and data analysis
Pure tone audiometry was performed according to current standards to determine air conduc-
tion thresholds at 0.25, 0.5, 1, 2, 3, 4, 6 and 8 kHz. Bone conduction thresholds were deter-
mined at 0.5, 1, 2 and 4 kHz in some patient to exclude conductive hearing impairment. After
validating binaural symmetry, the binaural mean air conduction threshold (dB Hearing Level,
HL) at each frequency was used for further analyses. An arbitrary value of 130 dB HL was used
to indicate out-of-scale measurements. Linear regression analyses of threshold on age were
used to evaluate progression of hearing impairment at individual frequencies. These analyses
comprised both individual longitudinal data derived from serial audiograms and overall cross-
sectional last-visit data. Progression was considered significant if the 95% confidence interval
for slope did not include zero for two or more frequencies. Progression was expressed in dB-
per-year and designated Annual Threshold Deterioration (ATD). Cross-sectional regression
data conformed to individual longitudinal regression data. Regression data from the last-visit
thresholds were used to derive Age-Related Typical Audiograms (ARTA), which show ex-
pected thresholds by decade steps in age [20].
Targeted genomic capture and whole exome sequencing
OtoSCOPE v1 was used to evaluate all known genetic causes of NSHL (including the non-
syndromic mimics like Usher Syndrome) in one affected individual (III.10), as previously de-
scribed [21,40]. Whole exome capture was performed with the Agilent SureSelectXT Human
All Exon V4 (Agilent Technologies, Santa Clara, CA) according to the manufacturer’s protocol.
All enriched libraries were sequenced on the Illumina HiSeq 2000 (Illumina, Inc., San Diego,
CA) using 100bp paired-end reads. Data analysis was performed on a local installation of Gal-
axy using the Burrows-Wheeler Alignment (BWA) for read mapping to the reference genome
(hg19, NCBI Build 37), Picard for removal of duplicate reads, GATK for local re-alignment
HOMER2 Disruption Causes Non-syndromic Hearing Loss
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and variant calling, and ANNOVAR and a custom workflow for variant annotation. Variant
filtering was based on: quality (>10X); minor allele frequency (MAF<0.0005) as reported in
the 1000 Genomes Project database and the National Heart, Lung, and Blood Institute
(NHLBI) Exome Sequencing Project Exome Variant Server (EVS). Variants were annotated for
conservation (GERP and PhyloP) and predicted pathogenicity (PolyPhen2, SIFT, MutationTa-
ster and LRT). Variants were then filtered based on coding effect (non-synonymous, indels and
splice-site variants); heterozygosity and allele sharing amongst the three sequenced affected in-
dividuals (II.2, IV.5, and IV.10). Sanger sequencing was completed in all family members to
confirm segregation of c.554G>C; p.Arg185Pro in HOMER2 gene (MIM 604799; RefSeq
NM_004839) using primers HOMER2-6F: 5’-ATGGGAGAGGCAGCAAGTCT-3’ and
HOMER2-6R: 5’-AGACCCACCTGCCAGCTTAC-3’.
Immunostaining
Cochleae from Balb/c mice were harvested at P2, locally perfused, fixed in 4% paraformalde-
hyde for 30min, and rinsed in PBS. Tissues were microdissected into cochlear and saccule sub-
sets and stored at 4°C in preparation for immunohistochemistry. Following infiltration using
0.3% Triton X-100 and blocking with 5% normal goat serum, we incubated the tissues in rabbit
HOMER2 polyclonal primary antibody (NB100-98712, Novus Biologicals, Littleton, CO) dilut-
ed 1:1000 in PBS overnight at 4°C. Specificity of HOMER2 antibody was confirmed by staining
whole mount cochlea from Homer2-/-mice (S7 Fig). Subsequently, a secondary antibody
Alexa-Fluor 568 Goat anti-rabbit (Life Technologies, Carlsbad, CA, USA; 1:1000) was applied
for 1h. Alexa-Fluor 488 phalloidin (Life Technologies, Carlsbad, CA, USA; 1:500) was added
for 15min to selectively visualize F-actin. We used anti-neurofilament 200 monoclonal primary
antibody (N0142, Sigma-Aldrich, Saint Louis, MO) and Alexa-Fluor 488 Goat anti-mouse as a
secondary antibody to visualize spiral ganglions neurons. Whole-mount tissues were mounted
in ProLong Gold Antifade Reagent (Life Technologies, Carlsbad, CA, USA). Confocal images
were collected using Leica TCS SP5 confocal microscope (Leica Microsystems Inc., Bannock-
burn, IL, USA) and analyzed in LSM 5 Image Browser and Adobe Photoshop.
Transfected HEK293T and COS7 cells were fixed in 4% paraformaldehyde in 0.1 M PBS
(pH 7.4); cells were permeabilized with 0.1% Trition-X100. Fixed cells were incubated with pri-
mary antibody at room temperature in PBS for 1.5hrs. The following primary antibodies were
used: monoclonal Anti-FLAG (Sigma-Aldrich, St. Louis, MO, USA; 1:400) and Anti-cMYC
(Sigma-Aldrich, St. Louis, MO, USA; 1:400). Secondary antibody incubation was for 1hr at
room temperature. Secondary antibodies used: Alexa-Fluor-488 goat anti-mouse (Invitrogen,
Grand Island, NY, USA; 1:500) to stain FLAG-tagged HOMER2 p.Arg185Pro and Alexa-Fluor-
568 goat anti-rabbit (Invitrogen, Grand Island, NY, USA; 1:500) to stain cMYC-tagged
HOMER2WT. F-actin was immuno-stained with Alexa-Fluor-647-phalloidin (Invitrogen,
Grand Island, NY, USA;1:500). Cells were mounted in SlowFade Gold Antifade Reagent with
DAPI (Life Technologies, Grand Island, NY, USA). Images were taken using a Zeiss LSM 510
with ZEN 2009 confocal microscope (Zeiss, Pleasanton, CA, USA).
Plasmid constructs
The Gateway PLUS shuttle clone for HOMER2 (AF081530.1) was ordered from GeneCopoeia
(GeneCopoeia Inc, Rockville, MD, USA). QuickChange Site-Directed Mutagenesis Kit (Strata-
gene, Cambridge, UK) was used for site-specific mutagenesis to introduce the P185 mutation
(S4 Table). The mutant expression plasmid was sequence verified. Both full length open reading
frames for WT protein HOMER2WT and mutant HOMER2p.Arg185Pro were cloned into the
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expression vectors pCMV-Tag3 (cMYC-tagged) and pCMV-Tag2 (FLAG-tagged), respectively
(Agilent technologies, Santa Clara, CA, USA). All constructs were verified by sequence analysis.
Cell culture
HEK293T cells and COS7 cells (ATCC, Manassas, VA, USA) were grown in Dulbecco's Modi-
fied Eagle's Medium (DMEM) supplemented with 10% FBS (Life Technologies, Carlsbad, CA,
USA). Cells were incubated in a 5% CO2-humidified incubator at 37°C. Cells were grown on
Poly-L-Lysine Coated coverslips (Corning, Tewksbury, MA, USA). Clonal cells were obtained
by transfection with Transit-LT Transfection Reagent (Mirus Bio, Madison, WI USA) using
cMYC-tagged HOMER2WT and FLAG-tagged HOMER2p.Arg185Pro plasmid constructs accord-
ing to the manufacturer’s instructions.
Morpholino knockdown and in vivo overexpression of mutant HOMER2
Zebrafish embryos were raised at 28.5°C as described [41]. All animal procedures were ap-
proved by the University of Iowa Office of Animal Resources (OAR) principle for the care and
use of laboratory animals and the Institutional Animal Care and Use Committee (IACUC).
Antisense morpholino oligonucleotides (MOs) were designed to block the exon/intron splice
junctions between exon 1 and intron 1 (MO i1e1 50- GGTACACATGTATCTGTCTGACCTT-
30) or intron 3 and exon 4 (50-CGCAATGAAAACTGTAAACACTCTT-30) of homer2
(ENSDART00000124088) and bought from Gene Tools (Philomath, OR, USA). They were in-
jected at 2.2 mg/ml along with 1 mg/ml p53 MO (5’-GCGCCATTGCTTTGCAAGAATTG-
3’). A standard control MO (5’-CCTCTTACCTCAGTTACAATTTATA-3’) was used for in-
jection of negative controls along with p53 MO. The efficacy of homer2 knockdown by each
morpholino was assessed by RT-PCR analysis with the following primer sets: forward (5’-
GGTTCCCGCCAGTAAACAG-3’) and reverse (5’-GTTTGAGCTCCGTCTTCAGG-3’),
which amplified the region between exons 1 and 12; B-actin primers were forward (50-
GAGATGATGCCCCTCGTG-3') and reverse 5'-GCTCAATGGGGTATTTGAGG-3'). MO
i1e1 morpholino was used for all subsequent experiments. For in vivomRNA synthesis,
HOMER2WT and HOMER2p.Arg185Pro plasmids were transferred into the expression vector
pCS2+ with Gateway LR Clonase according to the manufacturer’s instructions (Life Technolo-
gies, Carlsbad, CA, USA). This cDNA was used as a template for HOMER2 capped mRNA
synthesis using an Ambion mMESSAGE mMACHINE SP6 kit (Applied Biosystems, Foster
City, CA, USA), and the product was tested for quality and yield by electrophoresis and spec-
troscopy (NanoDrop Thermo Scientific, Waltham, MA, USA) before injection. Microinjection
was performed at the one- to two-cell stage using a microinjection system consisting of a SZX9
stereomicroscope (Olympus, Tokyo, Japan) and an IM300 Microinjector (Narishige, Tokyo,
Japan). Overexpression of injected mRNA was assessed by quantitative PCR with the following
primer sets: forward (5’-GACCCCAACACCAAGAAGAA-3’) and reverse
(5’CACTGTGTTGGCTCTGCTGT-3’). Primers for B-actin were forward (5’-CGCGCAGGA-
GATGGGAACC-3’) and reverse (5’-CAACGGAAACGCTCATTGC-3’).
Zebrafish hair cell staining
At 72 hours post fertilization (hpf), live larvae were submerged in 3 μM FM1-43 FX (Invitro-
gen, Grand Island, NY, USA) for 30 sec. They were then rinsed X3 in embryo media (ddH2O
with 5.03 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mMMgSO4, 0.1% w/v methylene
blue) and fixed in 4% paraformaldehyde. Before viewing, fish were rinsed X3 in PBS and
viewed in 75% glycerol, 25% PBS with a Zeiss 700 confocal microscope.
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Analysis of phenotypes in embryos and larvae
We focused on neuromasts that reside around the surface of the otic vesicle: o1, ml1, ml2, o2
and io4. Z-stacks were prepared using the max intensity z-projection function in ImageJ (NIH,
Stapleton, New York City, USA). The morphous and structure of otic vesicles was observed in
live larvae at 72hpf with a Leica MZFIII3 light microscope after anesthetizing with Tricaine.
Images were analyzed with ImageJ (NIH).
ABRs and DPOAEs
Mouse studies were carried out in accordance with University of Iowa Office of Animal Re-
sources (OAR) principle for the care and use of laboratory animals and the Institutional Ani-
mal Care and Use Committee (IACUC). Mice were culled using methods approved by the
American Veterinary Medical Association (AVMA) Guidelines for the Euthanasia of Animals.
The knockout Homer2-/- mice were donated by Paul F. Worley at John Hopkins University
(Baltimore, Maryland, USA). These mice have a neomycin cassette inserted into exon 3 of
Homer2 abolishing gene expression [31]. The Homer2 -/- colony was maintained on a C57BL/
6J background. Mice were genotyped by PCR, as previously described (S8 Fig and S4 Table)
[31]. Hearing thresholds were measured by click and tone burst (8, 16, and 32 kHz) ABR and
DPOAE inHomer2-/-, Homer2+/- and WTmice at two (P14), four (P28) and eight (P56) weeks.
At least 23 animals were tested at each time point. Mice were anesthetized using intraperitoneal
Ketamine/Xylazine at 0.1ml/10g body weight. Reference, ground and earth electrodes were
placed subcutaneously just posterior to the tested ear (left ear), anterior to the contralateral ear
and at the vertex of the head, respectively. ABRs were performed using an experimental setup
and testing protocol, as described [42]. Briefly, clicks and tone-bursts were delivered to the test-
ing ear through a plastic acoustic tube. ABRs were measured using an Etymotic Research
ER10B+ probe microphone (Etymotic Research, Elk Grove, IL, USA) coupled to two Tucker-
Davis Technologies MF1 multi-field magnetic speakers (Tucker-Davis Technologies, Alachua,
FL, USA). Click and tone-burst stimuli were presented and recorded using custom software
running on a PC connected to a 24-bit external sound card (Motu UltraLite mk3, Cambridge
MA, USA). A custom-built differential amplifier with a gain of 1,000 dB amplified acoustic
ABR responses. Output was passed through 6-pole Butterworth high-pass (100 Hz) and low-
pass (3 kHz) filters and then to a 16-bit analog-to-digital converter (100,000 sample/s). Re-
sponses were recorded using standard signal-averaging techniques for 500 or 1000 sweeps.
Hearing thresholds (db SPL) were determined by decreasing the sound intensity by 5 and/or
10 db decrements and recording the lowest sound intensity level resulting in a recognizable
and reproducible ABR response wave pattern. Maximum ABR thresholds were capped at
100 db SPL. DPOAEs were measured unilaterally (left ear) using an experimental setup and
testing protocol, as described [42]. In brief, DPOAE levels were elicited using two primary tone
stimuli, f1 and f2, with sound pressure levels of 65 and 55 db SPL, respectively, with f2/
f1 = 1.22. A custom plastic ear probe was inserted into the ear canal and DPOAE amplitudes
were measured at f2 frequencies at 4000, 5657, 8000, 11314, 16000, 22627 and 32000 Hz and
plotted after subtraction of noise floor amplitude.
Ingenuity pathway analysis (IPA)
IPA (Ingenuity Systems, Mountain View, CA, USA) was used to map interactions between
genes involved in NSHHL (86 genes) and HOMER2 and CDC42. Networks were created from
user-specified seed molecules by searching the knowledge base for molecules that are known to
biologically interact with the seeds and connecting them. Networks are displayed graphically as
nodes (genes/gene products) and edges (the biological relationships between the nodes). IPA
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computes a score for each network according to the fit of all significant genes. A detailed de-
scription is given in the online repository (http://www.ingenuity.com).
Statistical analysis
All results are displayed as mean ± standard error of the mean (mean ± SEM). Statistical analy-
ses were performed using one-way ANOVA (Zebrafish data) or one-way ANOVA with post
hoc T-test analysis using GraphPad Prism 6 (La Jolla, CA, USA) for ABR and DPOAE data.
P-values< 0.05 were assigned as significant.
Web resources
The URLs for data presented herein are as follows:
1000 Genomes; http://www.1000genomes.org
Hereditary Hearing Loss Homepage, http://hereditaryhearingloss.org
MutationTaster, http://www.mutationtaster.org
NHLBI Exome Sequencing Project Exome Variant Server; http://evs.gs.washington.edu/
EVS/
Online Mendelian Inheritance in Man (OMIM), http://www.omim.org/
PolyPhen-2, http://genetics.bwh.harvard.edu/pph2/
RefSeq, http://www.ncbi.nlm.nih.gov/RefSeq
SIFT, http://sift.jcvi.org/
Supporting Information
S1 Fig. Audiological features. (A) Longitudinal binaural mean air conduction threshold data
of affected family members. Age (years) is shown in symbol key. The panels are ordered (top
left to bottom right) by age at last visit. (B) Cross-sectional linear regression analysis of binau-
ral mean air conduction threshold on age (years) for each frequency separately. The regression
line (dashed) is included for each frequency. Annual threshold deterioration (ATD, in bold
print), that is the regression coefficient (dB/year), is included in each panel; asterisk indicates
significant progression.
(TIF)
S2 Fig. The p.Arg185Pro substitution does not alter subcellular localization of HOMER2.
(A-D) Confocal microscopy images show expression of HOMER2 throughout the cytoplasm
and co-localization of cMYC-tagged HOMER2WT and FLAG-tagged HOMER2 p.Arg185Pro pro-
teins expressed in HEK293T and COS7 cells. (A) Confocal images of cMYC-tagged
HOMER2WT-transfected HEK293 cells immuno-stained with Alexa-Fluor-568 (red); F-actin
immuno-stained with conjugated Alexa-Fluor-647-phalloidin (blue). (B) Confocal images of
FLAG-tagged HOMER2 p.Arg185Pro -transfected HEK293 cells immuno-stained with Alexa-
Fluor-488 (green); F-actin immuno-stained with conjugated Alexa-Fluor-647-phalloidin
(blue). (C) Confocal images of HEK293 cells co-transfected with cMYC-tagged HOMER2WT
and FLAG-tagged HOMER2 p.Arg185Pro immuno-stained with Alexa-Fluor-568 (red) and
Alexa-Fluor-488 (green), respectively; cell nuclei stained with DAPI (blue). (D) Confocal im-
ages of COS7 cells co-transfected with cMYC-tagged HOMER2WT and FLAG-tagged
HOMER2p.Arg185Pro immuno-stained with Alexa-Fluor-568 and Alexa-Fluor-488, respectively;
cell nuclei stained with DAPI (blue). The following primary antibodies were used: monoclonal
Anti-FLAG and Anti-c-MYC antibodies (Sigma-Aldrich). Scale bar represents 10 μm.
(TIF)
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S3 Fig. Knock down of homer2 in zebrafish embryos. (A) RT-PCR demonstrating knock
down of homer2 transcript using two morpholinos: MO e1i1 and MO i3e4. (B) Representative
morphology of otic capsules in zebrafish embryos at 72 hpf either injected with a control MO
or MO e1i1. (C) Otic capsule area was measured in 19 and 30 animals in the control and MO
groups, respectively. There was no statistically significant difference between groups. Scale bar
represents 50μm.
(TIF)
S4 Fig. Overexpression of mutant HOMER2 in zebrafish embryos. Quantitative PCR assess-
ing the relative quantity of mRNA from zebrafish embryos injected with WT HOMER2
(wtRNA) or HOMER2 P185-mutant RNA (P185RNA) demonstrates overexpression of both
injected mRNAs.
(TIF)
S5 Fig. Spiral ganglion morphology. (A-D)WTmice (n = 2). (E-H) Homer2-/-mice (n = 3).
(A and E) Cochlea from 3 month old mice stained with DAPI (blue). (B and F) Spiral gangli-
ons were labeled with anti-neurofilament antibody NF200 (green). (C and G)Merged pictures.
(D and H) Gross morphology of the organ of corti labeled with DAPI and NF200 shows no ob-
vious differences between WT and Homer2-/-mice. Scale bars in A-C and E-G: 50μm,D and
H: 100μm.
(TIF)
S6 Fig. HOMER2 interactome in the inner ear. Top-rated network generated by Ingenuity
Pathway Analysis (IPA) (Ingenuity Systems www.ingenuity.com) using 89 known NSHL-
causing genes (grey shade) and HOMER2 and CDC42 as seeds. A primary network (score 53)
containing 28 of the seed proteins was generated and shows multiple interactions between mol-
ecules. HOMER2 interacts directly with CDC42 and F-Actin. CDC42 interacts either directly
or indirectly with many proteins involved in NSHL (grey shade). Protein-protein interactions
are indicated by lines and arrows. A detailed legend for the network shapes and molecular rela-
tionships is found in the IPA network (http://ingenuity.force.com/ipa/articles/Feature_
Description/Legend).
(TIF)
S7 Fig. HOMER2 antibody specificity validation. (A) Staining with F-actin shows three rows
of OHCs and one row of IHCs in the cochlea. (B) Absence of Homer2 staining in the cochlea
ofHomer2-/-mice. (C)Merged pictures. Scale bar represents 10μm.
(TIF)
S8 Fig. Genotyping ofHomer2-/-,Homer2+/- andHomer2+/+mice by PCR. PCR products
were resolved on 2% agarose gel. The mutant allele corresponds to a 336-bp band. The wild
type allele corresponds to a 237-bp band.
(TIF)
S1 Table. WES and OtoSCOPE coverage statistics.
(DOCX)
S2 Table. Candidate variant list.
(DOCX)
S3 Table. Pathogenicity prediction for p.Arg185Pro mutation in HOMER2.
(DOCX)
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